Lv22
140 积分 2026-02-04 加入
Double Swords in One: Novel Selective PI3K/110β PROTAC Degraders for the Treatment of Multidrug-Resistant Cancer by Activating ERS and Inhibiting P-gp
9小时前
待确认
PROTAC-attractive site as a new target for suppressing P-glycoprotein activity
12小时前
已完结
DeepDegradome: A structure-aware deep learning framework for PROTAC and ligand generation against protein targets
1个月前
已完结
Understanding and overcoming multidrug resistance in cancer
1个月前
已完结
皖公网安备34019202002308
